🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Qlaris Phase 2 clinical study investigating the safety, tolerability, and o...
Status
Completed
Location
Berkeley Eye Center
Start Date
2024-04-21
Trial ID
NCT06249152
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of the fixe...
Status
Completed
Location
Research Center
Start Date
2006-06
Trial ID
NCT00393952
This is a two stage study, with an initial dose escalation phase I study an...
Status
Active Not Recruiting
Location
Velindre NHS Trust
Start Date
2014-05-07
Trial ID
NCT01992952
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
The primary purpose of this first-in-man study is to investigate whether a ...
Status
Completed
Location
Investigator Site
Start Date
2016-02-01
Trial ID
NCT02702648
The main purpose of this study is to evaluate the safety and effectiveness ...
Status
Recruiting
Location
Valleywise Health Medical Center
Start Date
2026-03-26
Trial ID
NCT07415044
This is a prospective, randomized, single blind, concurrent controlled, mul...
Status
Completed
Location
Hoag Hospital
Start Date
2012-04
Trial ID
NCT01584609
Treatments Being Tested
The study consists of two periods, the Screening Period (\~3 weeks) and Tre...
Status
Withdrawn
Location
Multiple Locations
Start Date
2015-06
Trial ID
NCT02435199
Treatments Being Tested
This is a randomized, double-blind, placebo-parallel intervention clinical ...
Status
Unknown
Location
The Second Affiliated Hospital of Chongqing Medical University
Start Date
2022-05-01
Trial ID
NCT06127498
The purpose of this study is to evaluate the abuse potential and safety of ...
Status
Completed
Location
Alkermes Investigational Site
Start Date
2014-08
Trial ID
NCT02218021
Treatments Being Tested